R A Walker

2.7k total citations
44 papers, 2.1k citations indexed

About

R A Walker is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, R A Walker has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Molecular Biology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in R A Walker's work include HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Breast Cancer Treatment Studies (7 papers). R A Walker is often cited by papers focused on HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Breast Cancer Treatment Studies (7 papers). R A Walker collaborates with scholars based in United Kingdom, United States and Canada. R A Walker's co-authors include Thomas G. Beach, E.G. McGeer, Mitch Dowsett, Ian O. Ellis, J. M. S. Bartlett, Sarah E. Pinder, David E. Woolley, Bharat Jasani, Keith Miller and Jeni Luckett and has published in prestigious journals such as Brain Research, Human Molecular Genetics and British Journal of Cancer.

In The Last Decade

R A Walker

43 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R A Walker United Kingdom 24 880 877 496 438 234 44 2.1k
Florence Boissière‐Michot France 25 1.3k 1.4× 775 0.9× 493 1.0× 308 0.7× 597 2.6× 75 2.3k
Norman L. Lehman United States 30 487 0.6× 1.1k 1.2× 285 0.6× 223 0.5× 163 0.7× 73 2.4k
Lionel M.L. Chow United States 30 500 0.6× 1.9k 2.2× 487 1.0× 242 0.6× 609 2.6× 56 3.2k
Hsin Chieh Lin United States 18 522 0.6× 2.4k 2.7× 555 1.1× 180 0.4× 252 1.1× 20 3.5k
Allan J. Yates United States 34 400 0.5× 2.2k 2.5× 709 1.4× 368 0.8× 315 1.3× 100 4.6k
Xiaolan Qian United States 31 1.2k 1.4× 2.0k 2.3× 374 0.8× 565 1.3× 245 1.0× 70 3.1k
Géza Sáfrány Hungary 27 489 0.6× 777 0.9× 291 0.6× 478 1.1× 437 1.9× 75 2.0k
Oliver Renner Spain 19 429 0.5× 1.8k 2.1× 478 1.0× 203 0.5× 223 1.0× 26 3.0k
Steven Swendeman United States 27 599 0.7× 1.7k 1.9× 267 0.5× 197 0.4× 508 2.2× 35 2.6k
John F. Reilly United States 25 572 0.7× 1.8k 2.1× 237 0.5× 127 0.3× 264 1.1× 43 3.0k

Countries citing papers authored by R A Walker

Since Specialization
Citations

This map shows the geographic impact of R A Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R A Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R A Walker more than expected).

Fields of papers citing papers by R A Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R A Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R A Walker. The network helps show where R A Walker may publish in the future.

Co-authorship network of co-authors of R A Walker

This figure shows the co-authorship network connecting the top 25 collaborators of R A Walker. A scholar is included among the top collaborators of R A Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R A Walker. R A Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Page, Karen, Natasha Hava, Brian Ward, et al.. (2011). Detection of HER2 amplification in circulating free DNA in patients with breast cancer. British Journal of Cancer. 104(8). 1342–1348. 68 indexed citations
2.
Bartlett, J. M. S., Jane Starczynski, Neil Atkey, et al.. (2011). HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods. Journal of Clinical Pathology. 64(8). 649–653. 56 indexed citations
3.
Walker, R A, J. M. S. Bartlett, Mitch Dowsett, et al.. (2008). HER2 testing in the UK: further update to recommendations. Journal of Clinical Pathology. 61(7). 818–824. 98 indexed citations
4.
Walker, R A. (2007). Immunohistochemical markers as predictive tools for breast cancer. Journal of Clinical Pathology. 61(6). 689–696. 54 indexed citations
5.
Hudson, E A, et al.. (2001). Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. British Journal of Cancer. 85(4). 618–624. 60 indexed citations
6.
Edwards, John, G. Cox, J. Louise Jones, et al.. (2001). Angiogenesis is an independent prognostic factor in malignant mesothelioma. British Journal of Cancer. 85(6). 863–868. 3 indexed citations
7.
Dowsett, Mitch, T Cooke, Ian O. Ellis, et al.. (2000). Assessment of HER2 status in breast cancer. European Journal of Cancer. 36(2). 170–176. 92 indexed citations
8.
Cox, G., et al.. (2000). Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer. Lung Cancer. 29(3). 169–177. 65 indexed citations
9.
Walker, R A. (2000). The significance of histological determination of HER-2 status in breast cancer. The Breast. 9(3). 130–133. 9 indexed citations
10.
Walker, R A & David E. Woolley. (1999). Immunolocalisation studies of matrix metalloproteinases-1, -2 and -3 in human melanoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 435(6). 574–579. 32 indexed citations
11.
Jones, J. Louise, et al.. (1997). Modulation of Myoepithelial-Associated α6β4 Integrin in a Breast Cancer Cell Line Alters Invasive Potential. Experimental Cell Research. 235(2). 325–333. 46 indexed citations
12.
Walker, R A, et al.. (1997). Case report: Nodular fasciitis of the breast. Clinical Radiology. 52(12). 961–962. 21 indexed citations
13.
Rye, Philip D. & R A Walker. (1994). Prognostic value of a breast cancer-associated glycoprotein detected by monoclonal antibody LU-BCRU-G7. European Journal of Cancer. 30(7). 1007–1012. 4 indexed citations
14.
Rye, Philip D. & R A Walker. (1993). Immunohistochemical Distribution of a Breast Cancer‐Associated Glycoprotein. Disease Markers. 11(2-3). 91–101. 1 indexed citations
15.
Dookeran, Keith A., Philip D. Rye, Sheila J. Dearing, & R A Walker. (1993). Expression of the pS2 peptide in primary breast carcinomas: Comparison of membrane and cytoplasmic staining patterns. The Journal of Pathology. 171(2). 123–129. 7 indexed citations
16.
Walker, R A, et al.. (1992). Differential expression of translation-associated genes in benign and malignant human breast tumours. British Journal of Cancer. 65(1). 65–71. 28 indexed citations
17.
Waites, G. T., Roger F.L. James, R A Walker, & Scott C. Bell. (1990). Human 'pregnancy-associated endometrial α1-globulin', a 32 kDa insulin-like growth factor-binding protein: immunohistological distribution and localization in the adult and fetus. Journal of Endocrinology. 124(2). 333–NP. 12 indexed citations
18.
Beach, Thomas G., R A Walker, & Edith G. McGeer. (1989). Lamina-selective A68 immunoreactivity in primary visual cortex of Alzheimer's disease patients. Brain Research. 501(1). 171–174. 13 indexed citations
19.
Waites, G. T., Paul L. Wood, R A Walker, & Scott C. Bell. (1988). Immunohistological localization of human endometrial secretory protein, 'pregnancy-associated endometrial α2-globulin' (α2-PEG), during the menstrual cycle. Reproduction. 82(2). 665–672. 45 indexed citations
20.
Woolley, David E., Raymond Whitehead, R A Walker, et al.. (1988). Mast Cell-Tumour Cell Interactions: Matrix Degradation and the Demonstration of Histamine H2 Receptors on Human Melanoma. Advances in experimental medicine and biology. 233. 81–90. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florence Boissière‐Michot Breakdown of academic impact, for papers by Norman L. Lehman Breakdown of academic impact, for papers by Lionel M.L. Chow Breakdown of academic impact, for papers by Hsin Chieh Lin Breakdown of academic impact, for papers by Allan J. Yates Breakdown of academic impact, for papers by Xiaolan Qian Breakdown of academic impact, for papers by Géza Sáfrány Breakdown of academic impact, for papers by Oliver Renner Breakdown of academic impact, for papers by Steven Swendeman Breakdown of academic impact, for papers by John F. Reilly
Rankless by CCL
2026